The IPO raised $48.7 million at an offer IPO raised $48.7 million at an offer price of $2.60 per share, which values Nuchev at a market capitalisation of $117 million.
Nuchev is an Australian-based, globally-orientated food business with a dedicated focus on developing and selling a range of premium Australian made goat nutritional products. Nuchev’s primary products are its Oli6 branded goat-milk infant formula (GIF) range, which is sold across multiple sales channels in Australia, China and Hong Kong. Management believes Nuchev is well-placed to seize a market-leading position in the rapidly growing and significant GIF market, where there is increasing awareness of the potential health benefits associated with GIF supported by scientific research.
Nuchev has achieved strong growth in sales revenue since 2016 when sales first commenced, and is forecast to grow revenue by 89% to $18 million in FY20.
Wilsons Advisory’s Head of Corporate Finance Origination, Richard Sherman commented, “Wilsons Advisory is excited to have successfully completed the IPO of Nuchev on the ASX. Nuchev is a high quality and differentiated infant formula player, with a well-established brand and business model and an attractive global market opportunity. The business is led by founder Ben Dingle, and supported by a deeply experienced and high quality management team and Board of Directors. We are pleased to have partnered with Nuchev throughout the IPO process, and we look forward to working alongside Nuchev in the years to come”.
Nuchev is expected to commence trading on the ASX on Monday, 9 December 2019. For further information, please contact your Wilsons Advisor.
About Wilsons Advisory: Wilsons Advisory is a financial advisory firm focused on delivering strategic and investment advice for people with ambition – whether they be a private investor, corporate, fund manager or global institution. Its client-first, whole of firm approach allows Wilsons Advisory to partner with clients for the long-term and provide the wide range of financial and advisory services they may require throughout their financial future. Wilsons Advisory is staff-owned and has offices across Australia.
Disclaimer: This communication has been prepared by Wilsons Advisory and Stockbroking Limited (ACN 010 529 665; AFSL 238375) and/or Wilsons Corporate Finance Limited (ACN 057 547 323; AFSL 238383) (collectively “Wilsons Advisory”). It is being supplied to you solely for your information and no action should be taken on the basis of or in reliance on this communication. To the extent that any information prepared by Wilsons Advisory contains a financial product advice, it is general advice only and has been prepared by Wilsons Advisory without reference to your objectives, financial situation or needs. You should consider the appropriateness of the advice in light of your own objectives, financial situation and needs before following or relying on the advice. You should also obtain a copy of, and consider, any relevant disclosure document before making any decision to acquire or dispose of a financial product. Wilsons Advisory's Financial Services Guide is available at wilsonsadvisory.com.au/disclosures.
All investments carry risk. Different investment strategies can carry different levels of risk, depending on the assets that make up that strategy. The value of investments and the level of returns will vary. Future returns may differ from past returns and past performance is not a reliable guide to future performance. On that basis, any advice should not be relied on to make any investment decisions without first consulting with your financial adviser. If you do not currently have an adviser, please contact us and we would be happy to connect you with a Wilsons Advisory representative.
To the extent that any specific documents or products are referred to, please also ensure that you obtain the relevant disclosure documents such as Product Disclosure Statement(s), Prospectus(es) and Investment Program(s) before considering any related investments.
Wilsons Advisory and their associates may have received and may continue to receive fees from any company or companies referred to in this communication (the “Companies”) in relation to corporate advisory, underwriting or other professional investment services. Please see relevant Wilsons Advisory disclosures at www.wilsonsadvisory.com.au/disclosures.
